$72.67
-2.07-2.78%
Last update: Nov 10, 1:29 PM

The average analyst price target for CG Oncology is $73.58, 1.3% above the current price. Of 16 analysts, 15 rate it Buy and 1 Hold. Targets range from $23 to $100. The latest change came on Nov 9, 2026, when Guggenheim lowered its price target on CG Oncology from $90 to $89 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 16 Analysts
Rating Trend — Last 9 Months